Gentell Executive and Leadership Team

Darryl D'Souza, the Chief Financial Officer at Gentell, governs the fiscal strategy and capital allocation for the medical manufacturing enterprise. D'Souza monitors revenue streams from wound care bundles and sanitizing product sales to ensure long-term financial stability. By analyzing market trends in the healthcare sector, the Chief Financial Officer provides the strategic insights necessary for sustainable growth and investment in new product development. This leadership role involves managing financial risk and optimizing cost structures across all manufacturing divisions. Darryl D'Souza drives profitability by overseeing budget alignment with the company's mission to supply high-quality dressings and skincare solutions. Through precise financial reporting and resource management, the Chief Financial Officer supports the expansion of market reach into new healthcare agencies. D'Souza ensures that fiscal policies remain robust, allowing the organization to maintain a competitive edge while delivering essential medical products to nursing homes and hospitals.

Kevin Quilty, the Chief Operating Officer at Gentell, manages the end-to-end manufacturing processes for wound care, skin protection, and sanitizing products. Quilty oversees production facilities to ensure consistent quality across hydrogel, alginate, and hydrocolloid dressing lines. By streamlining supply chain workflows, the Chief Operating Officer enhances the availability of essential medical supplies for hospitals and nursing homes. This leadership role involves coordinating with regional representatives to align production output with real-time market needs. Kevin Quilty drives operational excellence by implementing lean manufacturing principles that reduce waste and improve product efficacy. Through meticulous management of logistics and distribution networks, the Chief Operating Officer secures the timely delivery of barrier creams and odor eliminators to diverse healthcare environments. Quilty maintains high standards of regulatory compliance, ensuring every product meets the rigorous safety requirements necessary for clinical use in professional medical settings.

Roberto Schahin, the President, Gentell (Brazil) at Gentell, leads the strategic expansion and operational execution within the South American market. Schahin directs the introduction of advanced wound care and skin protection products to regional hospitals and healthcare agencies. By adapting the company's global product portfolio to local clinical needs, the President, Gentell (Brazil) ensures that hydrocolloid and transparent dressings meet specific regional regulatory standards. This leadership role involves building strong relationships with local medical providers and distributors to increase market penetration. Roberto Schahin drives growth by tailoring the distribution of soaps, sanitizers, and barrier creams to the unique requirements of the Brazilian healthcare landscape. Through effective management of regional teams, the President, Gentell (Brazil) establishes a strong brand presence. Schahin focuses on delivering consistent value to healthcare facilities, ensuring that the company's commitment to quality remains central to all regional operations and business development initiatives.

Brian Schorn, the President at Gentell, defines the overarching strategic vision for the company's wound care and skin protection product lines. Schorn directs the development of innovative dressings and sanitizing solutions, ensuring alignment with the evolving needs of hospitals and home health agencies. By fostering a culture of clinical excellence, the President guides the organization toward market leadership in medical supply manufacturing. This leadership role involves collaborating with other executives to refine the company's product bundles and service delivery models. Brian Schorn drives the expansion of the company's footprint by identifying new opportunities for product application in diverse healthcare settings. Through consistent focus on quality and patient outcomes, the President maintains the company's reputation as a trusted partner in wound care. Schorn oversees the integration of new technologies and manufacturing processes, ensuring that the organization remains at the forefront of the medical supply industry while delivering superior value to clients.

Michael Lebovics, the President at Gentell, manages the strategic partnerships and commercial relationships that drive the company's market presence. Lebovics oversees the sales and distribution channels for wound care products, ensuring that hospitals and nursing homes receive high-quality dressings and skincare solutions. By cultivating deep connections with healthcare providers, the President enhances the accessibility of the company's comprehensive product catalog. This leadership role involves setting commercial targets and aligning sales strategies with the company's broader mission of improving patient care. Michael Lebovics drives revenue growth by identifying and capturing new market segments for specialized products like collagen and silver dressings. Through effective leadership of the commercial team, the President ensures that the company's value proposition remains clear and compelling. Lebovics focuses on long-term sustainability, ensuring that the organization continues to provide essential medical supplies while adapting to the changing demands of the healthcare industry.

Frederic Brotz, the President at Gentell, leads the research and development initiatives focused on advancing the company's wound care and skin protection technologies. Brotz directs the engineering of new dressing materials, including advanced foam and alginate products, to improve clinical outcomes in nursing homes and hospitals. By prioritizing innovation, the President ensures that the company's product offerings remain at the cutting edge of medical science. This leadership role involves overseeing the transition from product concept to large-scale manufacturing. Frederic Brotz drives the development of specialized bundles that address complex wound care challenges, enhancing the company's competitive position. Through rigorous testing and quality assurance, the President maintains the highest standards for all skincare and sanitizing products. Brotz focuses on creating solutions that simplify clinical workflows, ensuring that healthcare professionals have the tools necessary to provide effective patient care while maintaining operational efficiency across the entire product portfolio.

Glenn Thompson, the Chief Information Officer at Gentell, directs the digital infrastructure supporting advanced wound care manufacturing and supply chain logistics. Thompson architects secure data systems that integrate hospital procurement platforms with internal production schedules, ensuring seamless product delivery to nursing homes and home health agencies. By modernizing enterprise resource planning tools, the Chief Information Officer optimizes inventory tracking for complex items like collagen and foam dressings. This leadership role involves protecting sensitive healthcare data while scaling digital capabilities across North American operations. Glenn Thompson drives technological efficiency to support the broader mission of providing superior skin protection products. Through rigorous oversight of cybersecurity protocols and software deployment, the Chief Information Officer maintains the operational integrity required for high-volume medical supply distribution. Constant innovation within the IT department enables the company to respond rapidly to shifting market demands in the medical manufacturing sector.